v3.25.2
Stock-Based Compensation (Tables)
 12 Months Ended
Apr. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The following table provides the estimated weighted average fair value for options granted during the years ended April 30 using the Black-Scholes option-pricing model, and the significant weighted average assumptions used in their determination:
20242023
Weighted average fair value of options on grant date$6.47 $9.24 
Weighted average assumptions:
Expected life of options (years)6.35.9
Risk-free interest rate4.6 %2.0 %
Expected volatility34.0 %32.4 %
Expected dividend yield4.6 %3.4 %
Fair value of common stock on grant date$30.37 $41.30 
Exercise price of stock option grant$34.86 $41.30 
Schedule of Share-based Payment Arrangement, Option, Activity
The following table summarizes the activity and status of our stock option plans during the year ended April 30, 2025:
Number
of Options
(in 000’s) 		Weighted
Average
Exercise
Price		Weighted
Average
Remaining
Term
(in years)		Aggregate
Intrinsic
Value
(in millions)
Outstanding at beginning of year375$48.74 
Granted—$— 
Exercised(7)$35.69 
Expired or forfeited(118)$53.50 
Outstanding at end of year250$46.87 7.4$1.2 
Exercisable at end of year143$55.28 6.7$0.3 
Vested and expected to vest in the future at April 30247$46.98 7.4$1.2 
Schedule of Share-based Payment Arrangement, Option, Exercise Price Range
The following table summarizes information about stock options outstanding and exercisable at April 30, 2025:
Options OutstandingOptions Exercisable
Range of Exercise PricesNumber
of Options
(in 000’s)		Weighted Average
Remaining
Term
(in years)		Weighted
Average
Exercise
Price		Number
of Options
(in 000’s)		Weighted
Average
Exercise
Price
$32.68 to $36.60
1378.5$34.91 37$34.94 
$45.99 to $63.07
1136.1$61.37 106$62.39 
Total/average2507.4$46.87 143$55.28 
Schedule of Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity
Activity for performance-based and other restricted stock awards during the years ended April 30, was as follows (shares in thousands):
202520242023
Restricted
Shares 		Weighted
Average
Grant Date
Value		Restricted
Shares 		Restricted
Shares
Nonvested shares at beginning of year1,203$37.07 1,0731,274
Granted735$43.06 1,089540
Change in shares due to performance71$39.83 54(44)
Vested and issued(448)$41.28 (660)(544)
Forfeited(345)$39.84 (353)(153)
Nonvested shares at end of year1,216$38.51 1,2031,073
Schedule of Share-Based Payment Arrangement, Expensed and Capitalized, Amount
We recognized stock-based compensation expense (including stock options) primarily in Operating and administrative expenses on the Consolidated Statements of Income (Loss), on a pretax basis, as follows:
For the Years Ended April 30,
202520242023
Stock-based compensation expense
$22,222 $24,982 $26,504 
Schedule of Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award The total grant date value of shares vested during the years ended April 30 was as follows:
202520242023
Grant date value of shares vested
$18,504 $29,874 $25,705